オーストラリア - 英語 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - azaperone - parenteral liquid/solution/suspension - azaperone anaesthetic active 40.0 mg/ml - central nervous system - pigs | boar | gilt | piglet | sow | swine - neuroleptic injection for pigs

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

oticon medical a division of audmet australia - 35368 - stimulator, evoked response, auditory - the neuro one is a behind the ear (bte) processor which captures and processes sounds in order to convert this acoustic information into stimulations frames sent to the implant. the sound captured by the two microphones inside the processor is digitally processed by the sound processor. the stimulation signal is then sent to the implant via the antenna through the skin. the neuro one behind the ear sound processor is a non-implantable component of the neuro cochlear implant system and is designed for adults and children of all ages, diagnosed with unilateral and bilateral severe to profound sensorineural hearing loss (and hearing aid use does not provide adequate amplification for speech audiometry), and is only compatible with the neuro zti cochlear implant.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

gkc manufacturing pty ltd - 61125 - neuromuscular motion disorder long-term ambulatory recorder/analyser - the parkinson's kinetigraph (pkg) system is intended to monitor physical motion and activity, to quantify kinematics of movement disorder symptoms, such as tremor, and assess activity in any instance where quantifiable analysis of motion and activity is desired.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

oticon medical a division of audmet australia - 47374 - cochlear implant system sound processor - the neuro 2 sound processor enables the functionality of the neuro zti implant by delivering the power and data required for electrical stimulation of the cochlea. without the processor, the implanted components will not function. the neuro 2 is powered by zinc air batteries or rechargeable batteries, with electrical components housed in a mechanical design to enable the patient to wear the processor behind the ear. the neuro 2 is a bte processor which captures and processes sounds in order to convert this acoustics information into stimulation frames sent to the implant. the external part is composed of a bte processor, and an antenna, connected through an antenna wire. the sound captured by the two microphones inside the processor is digitized and processed. the stimulation signal is then sent through the skin to the implant through the antenna and its wire. the antenna contains a magnet which allows it to keep its position in front of the implant.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

aimedical international pty ltd - 61124 - transcranial magnetic stimulation system, mobile - the device is a magnetic stimulator intended for non-invasive stimulation of neuromuscular tissue; brain, peripheral nervous system and spinal cord by electromagnetic pulses: inducing small currents in the tissue using a brief pulse of electromagnetic energy and responses can be recorded with eeg/emg for further evaluation.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

aimedical international pty ltd - 35747 - audiometer, auditory evoked response - the neuro-audio system is intended for use in electrophysiological and audiologic evaluation of hearing and vestibular function as an aid in detecting hearing loss and diagnosing hearing and vestibular related disorders. it can be used for screening and diagnostic applications. it allows recording auditory brainstem response (abr) and other auditory evoked potentials (aep), otoacoustic emissions (oae) and screening pure tone audiometry (pta). neuro-audio bone conduction amplifier unit is intended to record bone conduction vemps. the target population for neuro-audio includes all ages.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

aimedical international pty ltd - 11467 - electroencephalograph - neuron-spectrum are stationary and ambulatory digital eeg systems & are intended to perform clinical electroencephalography (eeg), video eeg, long-term monitoring (ltm), polysomnography (psg), cardiorespiratory monitoring and galvanic skin response (gsr) testing. additional intended use for the stationary systems include multimodality long-latency (including cognitive), middle-latency and short-latency evoked potential (ep) testing, emg (including needle and surface emg) testing, nerve conduction studies (ncs), electo-oculography (eog) testing, biological feedback (bfb) testing. the ambulatory system is not intended to allow direct diagnostics or monitoring of vital physiological processes, where the nature of variations could result in immediate danger to the patient for instance variations in cardiac performance, respiration, activity of central nervous system. to perform ep tests, the patient can be stimulated with built-in auditory, photic and pattern stimulators and optionally supplied high-resolution pattern-stimulator, and can be used with accessories such as neuro-mep auditory-visual stimulator, neuro-mep electrical stimulator control unit plugged in the same usb controller and third-party stimulators connected via electronic unit trig-in/out. the system can be used for the recording of physiological signals obtained in response to magnetic stimulation of central and peripheral nervous structures with magnetic stimulator and also for measurement of oxygen saturation level (spo2). all the obtained data are recorded, displayed, analysed, stored and printed. the system is intended to be used by trained operators under direct supervision of a licensed health care practitioner in adult and pediatric patients. the systems can be used in patients of all ages.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

vigor technologies pty ltd - 64759 - neuro-controlled joint movement exoskeleton - this product is aimed at assisting the training of voluntary exercises of the knee or elbow joint while the patient is lying or sitting on a bed or sitting on a chair, or in a standing posture with a fall-prevention measure. this product is designed mainly for those who: can be treated with exercise therapy, suffer from motor paralysis in the knee or elbow joint due to a stroke or spinal cord injury, have declined motor functions in the knee joint due to orthopedic surgery of the knee, or have muscle weakness due to aging or disuse (lack of use) syndrome.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

intermed medical pty ltd - 59689 - neuromuscular transmission electrode - tetrasens delivers electrical stimulation to the peripheral nerve

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

compliance management solutions - 59689 - neuromuscular transmission electrode - paingone arthro-fllow electrode pads are designed to be placed on the patient's skin in order to deliver an electrical stimulus to strengthen muscles that help support the knee and relieve pain associated with arthritis of the knee